Use the Pediatric Dosing Calculator for fast, accurate dosing
Lab
Efficiency
Implementing the American Society of Echocardiography (ASE) ultrasound enhancing agent guidelines into your facility's policy helps to ensure the appropriate use of DEFINITY® for improved patient care.1,2
Contrast Echo: See the Difference, Experience the Impact
Jonathan R. Lindner, MD, FACC, FASE, Lissa Sugeng, MD, MPH, FACC, FASE, and Rajesh Janardhanan, MD, MCRP, FACC, FASE, present the Lantheus 2015 ASE Science & Technology Theater Program.
DEFINITY® delivers clinical and economical value by improving diagnostic accuracy, lab efficiency, and workflow.3-5
Reduced resource utilization and per-patient expenses3
Eliminated the need for additional tests by 33%3
Associated with changes in use of vasoactive medications4
Reduced struggle time and may limit sonographer injury5,6,*
*Additional studies may be needed.
Decreased
procedure time5
May increase
patient throughput5,6
Peer-to-peer Programs
Lantheus offers multiple peer-to-peer programs to increase echo quality, enhance lab efficiency, reduce cost, and improve patient care.
Stay updated with the latest news from DEFINITY®
Get started with ordering and reimbursement
Explore the potential of DEFINITY® through our webinars
References:
-
Porter TR, Mulvagh SL, Abdelmoneim SS, et al. Clinical applications of ultrasonic enhancing agents in echocardiography: 2018 American Society of Echocardiography guidelines update. J Am Soc Echocardiogr. 2018;31(3):241-274. doi:10.1016/j.echo.2017.11.013
-
Mulvagh SL, Rakowski H, Vannan MA, et al. American Society of Echocardiography consensus statement on the clinical applications of ultrasonic contrast agents in echocardiography. J Am Soc Echocardiogr. 2008;21(11):1179-1281. doi:10.1016/j.echo.2008.09.009
-
Kurt M, Shaikh KA, Peterson L, et al. Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort. J Am Coll Cardiol. 2009;53(9):802-810. doi:10.1016/j.jacc.2009.01.005
-
Main ML, Fu JW, Gundrum J, LaPointe NA, Gillam LD, Mulvagh SL. Impact of contrast echocardiography on outcomes in critically ill patients. Am J Cardiol. 2021;150:117-122. doi:10.1016/j.amjcard.2021.03.039
-
Lester SJ, Askew JW, Hurst RT, et al. Contrast echocardiography: experience in a clinical echocardiography laboratory. J Am Soc Echocardiogr. 2006;19(7);919-923. doi:10.1016/j.echo.2006.01.025
-
Castello R, Bella JN, Rovner A, Swan J, Smith J, Shaw L. Efficacy and time-efficiency of a “sonographer-driven” contrast echocardiography protocol in a high-volume echocardiography laboratory. Am Heart J. 2003;145(3):535-541. doi:10.1067/mhj.2003.164
INDICATION
DEFINITY® is indicated, after activation, for use in adult and pediatric patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border.
IMPORTANT SAFETY INFORMATION
BOXED WARNING: SERIOUS CARDIOPULMONARY REACTIONS
Serious cardiopulmonary reactions, including fatalities, have occurred uncommonly during or following perflutren-containing microsphere administration. Most serious reactions occur within 30 minutes of administration.
- Assess all patients for the presence of any condition that precludes DEFINITY® administration.
- Always have resuscitation equipment and trained personnel readily available.
References:
- Porter TR, Mulvagh SL, Abdelmoneim SS, et al. Clinical applications of ultrasonic enhancing agents in echocardiography: 2018 American Society of Echocardiography guidelines update. J Am Soc Echocardiogr. 2018;31(3):241-274. doi:10.1016/j.echo.2017.11.013
- Mulvagh SL, Rakowski H, Vannan MA, et al. American Society of Echocardiography consensus statement on the clinical applications of ultrasonic contrast agents in echocardiography. J Am Soc Echocardiogr. 2008;21(11):1179-1281. doi:10.1016/j.echo.2008.09.009
- Kurt M, Shaikh KA, Peterson L, et al. Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort. J Am Coll Cardiol. 2009;53(9):802-810. doi:10.1016/j.jacc.2009.01.005
- Main ML, Fu JW, Gundrum J, LaPointe NA, Gillam LD, Mulvagh SL. Impact of contrast echocardiography on outcomes in critically ill patients. Am J Cardiol. 2021;150:117-122. doi:10.1016/j.amjcard.2021.03.039
- Lester SJ, Askew JW, Hurst RT, et al. Contrast echocardiography: experience in a clinical echocardiography laboratory. J Am Soc Echocardiogr. 2006;19(7);919-923. doi:10.1016/j.echo.2006.01.025
- Castello R, Bella JN, Rovner A, Swan J, Smith J, Shaw L. Efficacy and time-efficiency of a “sonographer-driven” contrast echocardiography protocol in a high-volume echocardiography laboratory. Am Heart J. 2003;145(3):535-541. doi:10.1067/mhj.2003.164
DEFINITY® Customer Service 1.800.299.3431
BACK TO TOP